Transaction in Own Shares

Summary by AI BETAClose X

On September 5, 2025, GSK plc announced the purchase of 284,800 of its ordinary shares with a nominal value of 31¼ pence each on September 4, 2025. The shares were bought at a lowest price of 1,451.00p and a highest price of 1,472.50p per share, with a volume-weighted average price of 1,464.66p. These shares will be held as treasury shares as part of an existing buyback program, bringing the total purchased since June 4, 2025, to 27,315,467 ordinary shares. Following this transaction, GSK holds 245,449,850 ordinary shares in treasury, with 4,069,946,246 ordinary shares in issue, excluding treasury shares; the treasury shares represent 6.03 percent of voting rights.

Disclaimer*

Companies

GSK (GSK)
UK 100

Latest directors dealings